Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Hong Theodore S.; Wo Jennifer Y.; Yeap Beow Y.; Ben-Josef Edgar; McDonnell Erin I.; Blaszkowsky Lawrence S.; Kwak Eunice L.; Allen Jill N.; Clark Jeffrey W.; Goyal Lipika; Murphy Janet E.; Javle Milind M.; Wolfgang John A.; Drapek Lorraine C.; Arellano Ronald S.; Mamon Harvey J.; Mullen John T.; Yoon Sam S.; Tanabe Kenneth K.; Ferrone Cristina R.; Ryan David P.; DeLaney Thomas F.; Crane Christopher H.; Zhu Andrew X.

首页> 外文期刊>Journal of Clinical Oncology >Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

【24h】

Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

机译：局部，不可切除的肝细胞癌和肝内胆管癌患者高剂量低频分频质子束治疗的多机构期II研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Purpose

机译：目的

著录项

来源
《Journal of Clinical Oncology》 |2016年第5期|共11页
作者
Hong Theodore S.; Wo Jennifer Y.; Yeap Beow Y.; Ben-Josef Edgar; McDonnell Erin I.; Blaszkowsky Lawrence S.; Kwak Eunice L.; Allen Jill N.; Clark Jeffrey W.; Goyal Lipika; Murphy Janet E.; Javle Milind M.; Wolfgang John A.; Drapek Lorraine C.; Arellano Ronald S.; Mamon Harvey J.; Mullen John T.; Yoon Sam S.; Tanabe Kenneth K.; Ferrone Cristina R.; Ryan David P.; DeLaney Thomas F.; Crane Christopher H.; Zhu Andrew X.;
展开▼
作者单位

Harvard Univ Sch Med Massachusetts Gen Hosp Cambridge MA 02138 USA;

Harvard Univ Sch Med Massachusetts Gen Hosp Cambridge MA 02138 USA;

Harvard Univ Sch Med Massachusetts Gen Hosp Cambridge MA 02138 USA;

Hosp Univ Penn 3400 Spruce St Philadelphia PA 19104 USA;

Harvard Univ Sch Med Massachusetts Gen Hosp Cambridge MA 02138 USA;

Harvard Univ Sch Med Massachusetts Gen Hosp Cambridge MA 02138 USA;

Harvard Univ Sch Med Massachusetts Gen Hosp Cambridge MA 02138 USA;

Harvard Univ Sch Med Massachusetts Gen Hosp Cambridge MA 02138 USA;

Harvard Univ Sch Med Massachusetts Gen Hosp Cambridge MA 02138 USA;

Harvard Univ Sch Med Massachusetts Gen Hosp Cambridge MA 02138 USA;

Harvard Univ Sch Med Massachusetts Gen Hosp Cambridge MA 02138 USA;

Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

Harvard Univ Sch Med Massachusetts Gen Hosp Cambridge MA 02138 USA;

Harvard Univ Sch Med Massachusetts Gen Hosp Cambridge MA 02138 USA;

Harvard Univ Sch Med Massachusetts Gen Hosp Cambridge MA 02138 USA;

Harvard Univ Sch Med Dana Farber Canc Inst Brigham &

Womens Hosp 44 Binney St Boston MA 02115;

Harvard Univ Sch Med Massachusetts Gen Hosp Cambridge MA 02138 USA;

Harvard Univ Sch Med Massachusetts Gen Hosp Cambridge MA 02138 USA;

Harvard Univ Sch Med Massachusetts Gen Hosp Cambridge MA 02138 USA;

Harvard Univ Sch Med Massachusetts Gen Hosp Cambridge MA 02138 USA;

Harvard Univ Sch Med Massachusetts Gen Hosp Cambridge MA 02138 USA;

Harvard Univ Sch Med Massachusetts Gen Hosp Cambridge MA 02138 USA;

Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

Harvard Univ Sch Med Massachusetts Gen Hosp Cambridge MA 02138 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma [J] . Hong Theodore S., Wo Jennifer Y., Yeap Beow Y., Journal of Clinical Oncology . 2016,第5期

机译：高剂量低分割质子束治疗局部，不可切除的肝细胞癌和肝内胆管癌的多机构II期研究
2. Hepatocyte Growth Factor is Associated With Liver Dysfunction and Survival: Biomarker Results of a Phase 2 Study of Proton Beam Therapy in Patients with Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma [J] . Hong T. S., Grassberger C., Yeap B. Y., International Journal of Radiation Oncology, Biology, Physics . 2017,第2Suppla期

机译：肝细胞生长因子与肝功能障碍和存活相关：生物标志物的肝细胞癌和肝内胆管癌患者的质子束治疗的2阶段研究
3. Phase I/II study of hepatic arterial infusion chemotherapy with gemcitabine in patients with unresectable intrahepatic cholangiocarcinoma (JIVROSG-0301). [J] . Inaba Y, Arai Y, Yamaura H, American Journal of Clinical Oncology: Cancer Clinical Trials . 2011,第1期

机译：I / II期吉西他滨治疗不可切除的肝内胆管癌患者的肝动脉灌注化疗（JIVROSG-0301）。
4. Deep Convolutional Neural Network for the Classification of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma [C] . Abhishck Midya, Jayasree Chakraborty, Linda M. Pak, SPIE Medical Imaging Conference . 2018

机译：深度卷积神经网络用于肝细胞癌和肝内胆管癌的分类
5. Transient increases in serum α fetoprotein and protein induced by vitamin K antagonist II levels following proton therapy does not necessarily indicate progression of hepatocellular carcinoma [D] . YOSHIDA MAIKO, 吉田舞子 2019

机译：质子治疗后血清α甲胎蛋白和维生素K拮抗剂II水平诱导的蛋白的短暂增加不一定表明肝细胞癌的进展
6. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma [O] . Theodore S. Hong, Jennifer Y. Wo, Beow Y. Yeap, -1

机译：高剂量低剂量质子束治疗局部不可切除的肝细胞癌和肝内胆管癌的多机构II期研究
7. Treatment-Induced Changes in Circulating Lymphocyte Populations Associate With Survival of Patients With Hepatocellular Carcinoma (HCC) and Intrahepatic Cholangiocarcinoma (ICC) Treated With Hypofractionated Proton Therapy (HPT) [O] . C. Grassberger, J.Y. Wo, T. Hato, 2016

机译：循环淋巴细胞群体的治疗诱导的变化与肝细胞癌（HCC）患者的存活和用次乳化物质疗法治疗（HPT）治疗的肝内胆碱和肝内胆管癌（ICC）

Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅